BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 18471523)

  • 21. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
    Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
    J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted reduction of KLF6-SV1 restores chemotherapy sensitivity in resistant lung adenocarcinoma.
    Sangodkar J; DiFeo A; Feld L; Bromberg R; Schwartz R; Huang F; Terzo EA; Choudhri A; Narla G
    Lung Cancer; 2009 Dec; 66(3):292-7. PubMed ID: 19328586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mutations of the tumor suppressor Kruppel-like factor 6 (KLF6) gene in hepatocellular carcinoma and its effect of growth suppression on human hepatocellular carcinoma cell line HepG2].
    Pan XC; Chen Z; Chen F; Chen XH; Zhou C; Yang ZG
    Zhonghua Gan Zang Bing Za Zhi; 2006 Feb; 14(2):109-13. PubMed ID: 16494780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinogen-induced hepatic tumors in KLF6+/- mice recapitulate aggressive human hepatocellular carcinoma associated with p53 pathway deregulation.
    Tarocchi M; Hannivoort R; Hoshida Y; Lee UE; Vetter D; Narla G; Villanueva A; Oren M; Llovet JM; Friedman SL
    Hepatology; 2011 Aug; 54(2):522-31. PubMed ID: 21563203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis.
    Narla G; DiFeo A; Fernandez Y; Dhanasekaran S; Huang F; Sangodkar J; Hod E; Leake D; Friedman SL; Hall SJ; Chinnaiyan AM; Gerald WL; Rubin MA; Martignetti JA
    J Clin Invest; 2008 Aug; 118(8):2711-21. PubMed ID: 18596922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration and dissemination.
    Ahronian LG; Zhu LJ; Chen YW; Chu HC; Klimstra DS; Lewis BC
    Oncogene; 2016 Sep; 35(35):4653-62. PubMed ID: 26876204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease.
    Miele L; Beale G; Patman G; Nobili V; Leathart J; Grieco A; Abate M; Friedman SL; Narla G; Bugianesi E; Day CP; Reeves HL
    Gastroenterology; 2008 Jul; 135(1):282-291.e1. PubMed ID: 18515091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KLF6 Gene and early melanoma development in a collagen I-rich extracellular environment.
    Huh SJ; Chen YL; Friedman SL; Liao J; Huang HJ; Cavenee WK; Robertson GP
    J Natl Cancer Inst; 2010 Aug; 102(15):1131-47. PubMed ID: 20660366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma.
    Kremer-Tal S; Reeves HL; Narla G; Thung SN; Schwartz M; Difeo A; Katz A; Bruix J; Bioulac-Sage P; Martignetti JA; Friedman SL
    Hepatology; 2004 Nov; 40(5):1047-52. PubMed ID: 15486921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma.
    Song J; Kim CJ; Cho YG; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1286-9. PubMed ID: 16872311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KLF6-SV1 drives breast cancer metastasis and is associated with poor survival.
    Hatami R; Sieuwerts AM; Izadmehr S; Yao Z; Qiao RF; Papa L; Look MP; Smid M; Ohlssen J; Levine AC; Germain D; Burstein D; Kirschenbaum A; DiFeo A; Foekens JA; Narla G
    Sci Transl Med; 2013 Jan; 5(169):169ra12. PubMed ID: 23345610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of KLF6 and its splice variant KLF6V on proliferation and differentiation of human hepatocellular carcinoma HepG2 cells].
    Pan XC; Chen Z; Ji F; Guo ZS; Chen M; Fu JJ
    Zhonghua Gan Zang Bing Za Zhi; 2008 Sep; 16(9):683-7. PubMed ID: 18822210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk.
    Narla G; Difeo A; Reeves HL; Schaid DJ; Hirshfeld J; Hod E; Katz A; Isaacs WB; Hebbring S; Komiya A; McDonnell SK; Wiley KE; Jacobsen SJ; Isaacs SD; Walsh PC; Zheng SL; Chang BL; Friedrichsen DM; Stanford JL; Ostrander EA; Chinnaiyan AM; Rubin MA; Xu J; Thibodeau SN; Friedman SL; Martignetti JA
    Cancer Res; 2005 Feb; 65(4):1213-22. PubMed ID: 15735005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination.
    DiFeo A; Narla G; Hirshfeld J; Camacho-Vanegas O; Narla J; Rose SL; Kalir T; Yao S; Levine A; Birrer MJ; Bonome T; Friedman SL; Buller RE; Martignetti JA
    Clin Cancer Res; 2006 Jun; 12(12):3730-9. PubMed ID: 16778100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis.
    Sirach E; Bureau C; Péron JM; Pradayrol L; Vinel JP; Buscail L; Cordelier P
    Cell Death Differ; 2007 Jun; 14(6):1202-10. PubMed ID: 17347668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth inhibitory effect of Krüppel-like factor 6 on human prostatic carcinoma and renal carcinoma cell lines.
    Cheng XF; Li D; Zhuang M; Chen ZY; Lu DX; Hattori T
    Tohoku J Exp Med; 2008 Sep; 216(1):35-45. PubMed ID: 18719336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease.
    Bechmann LP; Gastaldelli A; Vetter D; Patman GL; Pascoe L; Hannivoort RA; Lee UE; Fiel I; Muñoz U; Ciociaro D; Lee YM; Buzzigoli E; Miele L; Hui KY; Bugianesi E; Burt AD; Day CP; Mari A; Agius L; Walker M; Friedman SL; Reeves HL
    Hepatology; 2012 Apr; 55(4):1083-93. PubMed ID: 22095588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced hepatic stellate cell expression of Kruppel-like factor 6 tumor suppressor isoforms amplifies fibrosis during acute and chronic rodent liver injury.
    Ghiassi-Nejad Z; Hernandez-Gea V; Woodrell C; Lang UE; Dumic K; Kwong A; Friedman SL
    Hepatology; 2013 Feb; 57(2):786-96. PubMed ID: 22961688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TGF-beta regulates the expression of transcription factor KLF6 and its splice variants and promotes co-operative transactivation of common target genes through a Smad3-Sp1-KLF6 interaction.
    Botella LM; Sanz-Rodriguez F; Komi Y; Fernandez-L A; Varela E; Garrido-Martin EM; Narla G; Friedman SL; Kojima S
    Biochem J; 2009 Apr; 419(2):485-95. PubMed ID: 19076057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Krüppel-like factor 6 interferes with cellular transformation induced by the H-ras oncogene.
    Trucco LD; Andreoli V; Núñez NG; Maccioni M; Bocco JL
    FASEB J; 2014 Dec; 28(12):5262-76. PubMed ID: 25212220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.